Lab values

Creatinine lab values

Creatinine is a waste product of normal muscle activity. Healthy kidneys filter it out of the blood and pass it in the urine, so the serum level rises when filtration falls. It is ordered on a basic or comprehensive metabolic panel to screen and follow kidney function, to watch for kidney effects of medicines, and to calculate the estimated glomerular filtration rate (eGFR). It is read together with BUN.

Checked against the sources below November 2026

Normal range

TestUS unitsSI unitsNotes
Creatinine0.7–1.3 mg/dL (men), 0.6–1.1 mg/dL (women)62–115 µmol/L (men), 53–97 µmol/L (women)

Adult ranges. Ranges differ a little between laboratories; use the range printed on your lab’s report. All chemistry values

Creatinine in the ICU

Elevated creatinine

KDIGO defines acute kidney injury as a rise of 0.3 mg/dL or more within 48 hours, or 1.5 times baseline within 7 days. Stage 3 includes a level of 4.0 mg/dL or more.

Causes

Signs and symptoms

Nursing actions

  1. Measure intake and output strictly and report urine output below 0.5 mL/kg/hour.
  2. Weigh the client daily on the same scale and assess for edema and crackles.
  3. Check potassium, bicarbonate and phosphate with each panel and report rising potassium at once.
  4. Review the medication list and hold or clarify nephrotoxic and renally cleared drugs with the prescriber.
  5. Check a urinary catheter for kinks or clots and anticipate a bladder scan when obstruction is possible.
  6. Anticipate an order to restrict fluid, sodium and potassium in oliguric injury.
  7. Monitor for confusion, asterixis and a pericardial rub and report them as signs of worsening uremia.

Low creatinine

A low result is uncommon. It usually reflects low muscle mass rather than better kidney function, and it can make eGFR look better than it really is.

Causes

Signs and symptoms

Nursing actions

  1. Assess nutrition, weight trend and muscle mass.
  2. Report a low creatinine with an eGFR that seems out of line with the client's condition.
  3. Anticipate an order for cystatin C or a measured clearance when eGFR and the client's build do not match.
  4. Collaborate with the dietitian on protein and calorie intake as ordered.

Drawing and reading the sample

On the exam

Check yourself: 4 questions

Question 1 · Vasopressors & Inotropes

A patient on milrinone 0.5 mcg/kg/min develops AKI, with creatinine rising from 1.0 to 2.8 mg/dL, and increasing hypotension. Why should the nurse promptly notify the provider?

  1. Milrinone binds potassium and worsens hyperkalemia
  2. Milrinone needs high urine output to work
  3. It is renally cleared; accumulation deepens hypotension
  4. Milrinone is directly nephrotoxic to the tubules
Show the answer and rationale

Answer: C

  • A. Milrinone does not bind potassium.
  • B. Milrinone’s effect does not depend on urine output.
  • C. Correct. Reduced clearance prolongs milrinone’s half-life, and accumulation causes vasodilation and arrhythmias that persist after the dose is reduced.
  • D. Milrinone is not a direct nephrotoxin. The problem is reduced clearance.

Milrinone is eliminated mainly unchanged by the kidneys, with a half-life of about 2–3 hours that lengthens markedly in renal impairment. In AKI, levels accumulate, causing prolonged hypotension and arrhythmias that do not resolve quickly after the infusion is reduced, unlike dobutamine, which clears within minutes. Doses are reduced for kidney dysfunction, and dobutamine may be preferred when renal function is unstable.

Sources: Elsevier's 2025 Intravenous Medications; Mosby's 2026 Nursing Drug Reference

Question 2 · Cardiac Surgery & Post-op Care

On the evening after CABG, a patient on norepinephrine 0.04 mcg/kg/min has MAP 68 mm Hg, and creatinine has risen from 1.1 to 1.4 mg/dL. The home medication reconciliation includes lisinopril 20 mg daily, and the order is to “resume home medications tonight.” Which action is MOST appropriate?

  1. Give the lisinopril and increase the norepinephrine as needed
  2. Give the lisinopril, since it protects the heart long term
  3. Clarify the order and hold lisinopril for now
  4. Give half the dose to balance the risks
Show the answer and rationale

Answer: C

  • A. Adding a vasodilator while escalating a vasopressor is counterproductive.
  • B. Giving it now could worsen hypotension and kidney injury.
  • C. Correct. ACE inhibitors are held early after cardiac surgery while patients are on vasopressors or have evolving AKI.
  • D. Even a reduced dose can worsen vasodilation and AKI in this setting.

ACE inhibitors and ARBs contribute to vasoplegia and can worsen AKI early after cardiopulmonary bypass. They are generally held while patients need vasopressors, are hemodynamically unstable, or have rising creatinine, and are restarted once BP and kidney function are stable, often before discharge in patients with reduced EF, recent MI, diabetes, or CKD. Reconciliation of home medications considers the patient’s current physiology.

Sources: Hardin & Kaplow, Cardiac Surgery, 4th ed.; Bojar, Cardiac Surgery Periop Care, 6th ed.

Question 3 · Advanced ICU Pharmacology

A patient with septic shock develops AKI, with creatinine rising from 0.9 to 2.8 mg/dL and a creatinine clearance of about 25 mL/min. The nurse reviews the medication list. Which order is MOST important to clarify for renal dose adjustment?

  1. Acetaminophen 650 mg every 6 hours as needed
  2. A propofol infusion titrated to RASS
  3. Enoxaparin 1 mg/kg subcutaneously every 12 hours
  4. Norepinephrine titrated to a MAP of 65 or higher
Show the answer and rationale

Answer: C

  • A. Acetaminophen is hepatically cleared and does not need renal dose adjustment.
  • B. Propofol is hepatically metabolized and titrated to effect.
  • C. Correct. Enoxaparin is renally cleared, and full doses with a CrCl below 30 accumulate and cause bleeding.
  • D. Vasopressors are titrated to effect and are not renally dose-adjusted.

AKI changes the clearance of many drugs. Renally cleared drugs that need adjustment or level monitoring include LMWH (enoxaparin is reduced to once daily when CrCl is below 30), vancomycin and aminoglycosides (level-guided dosing), many β-lactams, gabapentin, famotidine, milrinone, and some opioids (morphine metabolites accumulate). Nurses play a key role in recognizing nephrotoxins (NSAIDs, contrast, vancomycin combined with piperacillin–tazobactam) and prompting pharmacy review.

Sources: Mosby's 2026 Nursing Drug Reference; Saunders Nursing Drug Handbook 2021

Question 4 · Advanced ICU Pharmacology

An 82-year-old patient with nonvalvular AF who weighs 58 kg and has a creatinine of 1.1 mg/dL is starting apixaban. Which dose is appropriate?

  1. 2.5 mg twice daily
  2. 10 mg twice daily for 7 days, then 5 mg twice daily
  3. 5 mg twice daily
  4. 5 mg once daily
Show the answer and rationale

Answer: A

  • A. Correct. The patient meets two dose-reduction criteria: age 80 or older and weight 60 kg or less.
  • B. This is the VTE treatment regimen, not the AF dose.
  • C. The standard dose applies when fewer than two reduction criteria are present.
  • D. Apixaban is dosed twice daily for AF.

For AF, apixaban 5 mg twice daily is reduced to 2.5 mg twice daily when a patient has at least two of three criteria: age 80 or older, weight 60 kg or less, or serum creatinine 1.5 mg/dL or higher. Inappropriate underdosing is common and increases stroke risk, so the nurse checks that the criteria are actually met. Strong dual CYP3A4 and P-gp inhibitors also affect dosing.

Sources: ACC/AHA/ACCP/HRS AF Guideline (2023); Saunders Nursing Drug Handbook 2023

Practice this in the app

ICU Basics has 85 questions on electrolyte imbalances, each with a rationale for every choice. No ads. Pro is coming in January 2027.

Practice in your browser

Download on theApp StoreGet it onGoogle Play

Study the topic

Electrolyte Imbalance practice questions

Other lab values

Sources

  1. MedlinePlus. Creatinine Test. Accessed 2026.
  2. Merck Manual Professional Version. Acute Kidney Injury (AKI). Accessed 2026.
  3. Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Critical Care. 2013.
  4. Takita H, et al. Physiologically-based pharmacokinetic modelling of creatinine-drug interactions in the chronic kidney disease population. CPT Pharmacometrics Syst Pharmacol. 2020.
  5. Nankivell BJ, et al. How unmeasured muscle mass affects estimated GFR and diagnostic inaccuracy. EClinicalMedicine. 2020.
  6. Reference range: MedlinePlus Medical Encyclopedia ranges (National Library of Medicine, reviewed 2024–2026); ABIM laboratory reference ranges (January 2026) for hemoglobin, hematocrit and potassium; Merck Manual for ionized calcium; the heparin label for the aPTT target; ASHP/IDSA 2020 vancomycin guideline

For education and exam preparation only. Reference ranges and critical values vary by laboratory. Follow your facility’s policy and the prescriber’s orders.